Tümgör G et al. |
A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. |
2014 |
Turk J Gastroenterol |
pmid:25599790
|
Dinçkan A et al. |
Evaluation of the first 100 liver transplantations. |
2008 |
Turk J Gastroenterol |
pmid:18386237
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Vathsala A et al. |
Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation. |
1990 |
Transplantation |
pmid:1689520
|
Levy G et al. |
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. |
2004 |
Transplantation |
pmid:15201658
|
Adams PS et al. |
Postoperative cardiac tamponade after kidney transplantation: a possible consequence of alemtuzumab-induced cytokine release syndrome. |
2013 |
Transplantation |
pmid:23380870
|
Ajiki T et al. |
Generation of donor hematolymphoid cells after rat-limb composite grafting. |
2003 |
Transplantation |
pmid:12640301
|
Tsuchiya N et al. |
Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients. |
2004 |
Transplantation |
pmid:15502717
|
Shield CF et al. |
Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9422413
|
David-Neto E et al. |
The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients. |
2007 |
Transplantation |
pmid:17627237
|
Takeguchi N et al. |
Inhibition of the multidrug efflux pump in isolated hepatocyte couplets by immunosuppressants FK506 and cyclosporine. |
1993 |
Transplantation |
pmid:7681229
|
Demetris AJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. |
1992 |
Transplantation |
pmid:1374944
|
Bundick RV et al. |
FK506 as an agonist to induce inhibition of interleukin 2 production. |
1992 |
Transplantation |
pmid:1374947
|
Al-Uzri A et al. |
Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). |
2001 |
Transplantation |
pmid:11579294
|
Roy A et al. |
Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant. |
2006 |
Transplantation |
pmid:16926593
|
Welberry Smith MP et al. |
Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial. |
2013 |
Transplantation |
pmid:24056618
|
Yang Z et al. |
Long-term liver allograft survival induced by combined treatment with rAAV-hCTLA4Ig gene transfer and low-dose FK506. |
2003 |
Transplantation |
pmid:12589149
|
Esquivel CO et al. |
Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. |
1996 |
Transplantation |
pmid:8607198
|
Zhao WY et al. |
Single kidneys transplanted from small pediatric donors less than 15 kilograms into pediatric recipients. |
2014 |
Transplantation |
pmid:25955345
|
Nogueira JM et al. |
A comparison of recipient renal outcomes with laparoscopic versus open live donor nephrectomy. |
1999 |
Transplantation |
pmid:10096529
|
Egawa H et al. |
Isolated alkaline phosphatemia following pediatric liver transplantation in the FK506 ERA. |
1995 |
Transplantation |
pmid:7533958
|
Franz M et al. |
Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy? |
1998 |
Transplantation |
pmid:9825827
|
Guerville F et al. |
Transplantation with pathologic kidneys to improve the pool of donors: an example of shunt nephritis. |
2012 |
Transplantation |
pmid:22487813
|
Mathis AS et al. |
Sex and ethnicity may chiefly influence the interaction of fluconazole with calcineurin inhibitors. |
2001 |
Transplantation |
pmid:11374405
|
McDiarmid SV et al. |
Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients. |
1993 |
Transplantation |
pmid:7685933
|
Singla AK et al. |
Cerulomycin Caerulomycin [corrected] A: a potent novel immunosuppressive agent. |
2014 |
Transplantation |
pmid:24949498
|
Chapman WC et al. |
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. |
2017 |
Transplantation |
pmid:28121741
|
Walsh C et al. |
Anti-CD25 monoclonal antibody replacement therapy for chronic kidney disease in liver transplant recipients. |
2013 |
Transplantation |
pmid:23296149
|
Becker T et al. |
Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. |
2008 |
Transplantation |
pmid:19104406
|
Oike F et al. |
A 12-day course of FK506 allows long-term acceptance of semi-identical liver allograft in inbred miniature swine. |
2000 |
Transplantation |
pmid:10868630
|
Yamani MH et al. |
The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. |
2000 |
Transplantation |
pmid:10868634
|
Gloor JM et al. |
Subclinical rejection in tacrolimus-treated renal transplant recipients. |
2002 |
Transplantation |
pmid:12131699
|
Borni-Duval C et al. |
Risk factors for BK virus infection in the era of therapeutic drug monitoring. |
2013 |
Transplantation |
pmid:23778568
|
Jain A et al. |
Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation. |
2005 |
Transplantation |
pmid:16210976
|
Mourer JS et al. |
Late calcineurin inhibitor withdrawal prevents progressive left ventricular diastolic dysfunction in renal transplant recipients. |
2012 |
Transplantation |
pmid:22955227
|
Florman S et al. |
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients. |
2007 |
Transplantation |
pmid:17589349
|
Yoo MC et al. |
Steroid-free Liver Transplantation Using Rabbit Antithymocyte Globulin Induction in 500 Consecutive Patients. |
2015 |
Transplantation |
pmid:25539464
|
Dean PG et al. |
Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. |
2004 |
Transplantation |
pmid:15239621
|
Tian L et al. |
Association of the CD134/CD134L costimulatory pathway with acute rejection of small bowel allograft. |
2002 |
Transplantation |
pmid:12134113
|
Gillard P et al. |
Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts. |
2008 |
Transplantation |
pmid:18212631
|
Ryu S and Yasunami Y |
The necessity of differential immunosuppression for prevention of immune rejection by FK506 in rat islet allografts transplanted into the liver or beneath the kidney capsule. |
1991 |
Transplantation |
pmid:1718064
|